BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 2530761)

  • 1. A placebo-controlled, double-blind, clinical trial of paroxetine in depressed outpatients.
    Rickels K; Amsterdam J; Clary C; Fox I; Schweizer E; Weise C
    Acta Psychiatr Scand Suppl; 1989; 350():117-23. PubMed ID: 2530761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paroxetine in the treatment of depression: a comparison with imipramine and placebo.
    Feighner JP; Boyer WF
    Acta Psychiatr Scand Suppl; 1989; 350():125-9. PubMed ID: 2530763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A placebo- and imipramine-controlled study of paroxetine.
    Cohn JB; Crowder JE; Wilcox CS; Ryan PJ
    Psychopharmacol Bull; 1990; 26(2):185-9. PubMed ID: 2146697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.
    Detke MJ; Wiltse CG; Mallinckrodt CH; McNamara RK; Demitrack MA; Bitter I
    Eur Neuropsychopharmacol; 2004 Dec; 14(6):457-70. PubMed ID: 15589385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The therapeutic efficacy of paroxetine: (a) an open study in patients with major depression not responding to antidepressants; (b) a double-blind comparison with amitriptyline in depressed outpatients.
    Gagiano CA; Müller PG; Fourie J; Le Roux JF
    Acta Psychiatr Scand Suppl; 1989; 350():130-1. PubMed ID: 2530765
    [No Abstract]   [Full Text] [Related]  

  • 6. The safety and efficacy of paroxetine compared with placebo in a double-blind trial of depressed outpatients.
    Claghorn JL
    J Clin Psychiatry; 1992 Feb; 53 Suppl():33-5. PubMed ID: 1531821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A double-blind comparison of paroxetine and placebo in the treatment of depressed patients in a psychiatric outpatient clinic.
    Miller SM; Naylor GJ; Murtagh M; Winslow G
    Acta Psychiatr Scand Suppl; 1989; 350():143-4. PubMed ID: 2530772
    [No Abstract]   [Full Text] [Related]  

  • 8. A double-blind, placebo-controlled study of paroxetine in depressed outpatients.
    Kiev A
    J Clin Psychiatry; 1992 Feb; 53 Suppl():27-9. PubMed ID: 1531818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A double-blind study to compare the effectiveness and tolerability of paroxetine and amitriptyline in depressed patients.
    Bascara L
    Acta Psychiatr Scand Suppl; 1989; 350():141-2. PubMed ID: 2530771
    [No Abstract]   [Full Text] [Related]  

  • 10. A placebo-controlled trial of paroxetine in the treatment of major depression.
    Smith WT; Glaudin V
    J Clin Psychiatry; 1992 Feb; 53 Suppl():36-9. PubMed ID: 1531822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paroxetine versus placebo: a double-blind comparison in depressed patients.
    Claghorn JL; Kiev A; Rickels K; Smith WT; Dunbar GC
    J Clin Psychiatry; 1992 Dec; 53(12):434-8. PubMed ID: 1487471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A double-blind, multicentre study of paroxetine versus clomipramine in depressed elderly patients.
    Guillibert E; Pelicier Y; Archambault JC; Chabannes JP; Clerc G; Desvilles M; Guibert M; Pagot R; Poisat JL; Thobie Y
    Acta Psychiatr Scand Suppl; 1989; 350():132-4. PubMed ID: 2530766
    [No Abstract]   [Full Text] [Related]  

  • 13. A comparison of paroxetine, imipramine and placebo in depressed out-patients.
    Dunbar GC; Cohn JB; Fabre LF; Feighner JP; Fieve RR; Mendels J; Shrivastava RK
    Br J Psychiatry; 1991 Sep; 159():394-8. PubMed ID: 1835664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A double-blind study of paroxetine, fluoxetine, and placebo in outpatients with major depression.
    Fava M; Amsterdam JD; Deltito JA; Salzman C; Schwaller M; Dunner DL
    Ann Clin Psychiatry; 1998 Dec; 10(4):145-50. PubMed ID: 9988054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The efficacy and safety of paroxetine compared with placebo in outpatients with major depression.
    Rickels K; Amsterdam J; Clary C; Fox I; Schweizer E; Weise C
    J Clin Psychiatry; 1992 Feb; 53 Suppl():30-2. PubMed ID: 1531820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A 6-week, double-blind trial of paroxetine, imipramine, and placebo in depressed outpatients.
    Fabre LF
    J Clin Psychiatry; 1992 Feb; 53 Suppl():40-3. PubMed ID: 1531823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A double-blind comparison of paroxetine, imipramine, and placebo in major depression.
    Shrivastava RK; Shrivastava SH; Overweg N; Blumhardt CL
    J Clin Psychiatry; 1992 Feb; 53 Suppl():48-51. PubMed ID: 1531825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A double-blind study of the comparative antidepressant effect of paroxetine and amitriptyline.
    Kuhs H; Rudolf GA
    Acta Psychiatr Scand Suppl; 1989; 350():145-6. PubMed ID: 2530773
    [No Abstract]   [Full Text] [Related]  

  • 19. A double-blind, multicentre study of paroxetine and mianserin in depression.
    Mertens C; Pintens H
    Acta Psychiatr Scand Suppl; 1989; 350():140. PubMed ID: 2530770
    [No Abstract]   [Full Text] [Related]  

  • 20. Paroxetine in the treatment of depression. A double-blind multicenter study versus mianserin.
    Mertens C; Pintens H
    Acta Psychiatr Scand; 1988 Jun; 77(6):683-8. PubMed ID: 2970203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.